{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:56:08Z","timestamp":1775123768426,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,2]]},"DOI":"10.7759\/cureus.106315","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:01:36Z","timestamp":1775120496000},"source":"Crossref","is-referenced-by-count":0,"title":["Fracture Healing and Commonly Co-Prescribed Medications: Orthopedic Implications in Multimorbid Patients: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Yash","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babajide","family":"Obidigbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikedichim","family":"Nwankwo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-199810001-00003","article-title":"The cell and molecular biology of fracture healing","author":"Einhorn TA","year":"1998","unstructured":"Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res. 1998, S7-21. 10.1097\/00003086-199810001-00003","journal-title":"Clin Orthop Relat Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2011.03.031","article-title":"The biology of fracture healing","volume":"42","author":"Marsell R","year":"2011","unstructured":"Marsell R, Einhorn TA. The biology of fracture healing. Injury. 2011, 42:551-5. 10.1016\/j.injury.2011.03.031","journal-title":"Injury"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.1","article-title":"Fracture healing under healthy and inflammatory conditions","volume":"8","author":"Claes L","year":"2012","unstructured":"Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol. 2012, 8:133-43. 10.1038\/nrrheum.2012.1","journal-title":"Nat Rev Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-1383(08)70003-2","article-title":"Fracture healing: the diamond concept","volume":"38","author":"Giannoudis PV","year":"2007","unstructured":"Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: the diamond concept. Injury. 2007, 38:3-6. 10.1016\/S0020-1383(08)70003-2","journal-title":"Injury"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-1383(07)80004-0","article-title":"Risk factors contributing to fracture non-unions","volume":"38","author":"Calori GM","year":"2007","unstructured":"Calori GM, Albisetti W, Agus A, et al.. Risk factors contributing to fracture non-unions. Injury. 2007, 38:11. 10.1016\/S0020-1383(07)80004-0","journal-title":"Injury"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.2775","article-title":"Epidemiology of fracture nonunion in 18 human bones","volume":"151","author":"Zura R","year":"2016","unstructured":"Zura R, Xiong Z, Einhorn T, et al.. Epidemiology of fracture nonunion in 18 human bones. JAMA Surg. 2016, 151:e162775. 10.1001\/jamasurg.2016.2775","journal-title":"JAMA Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15122845","article-title":"Incidence, costs and predictors of non-union, delayed union and mal-union following long bone fracture","volume":"15","author":"Ekegren CL","year":"2018","unstructured":"Ekegren CL, Edwards ER, de Steiger R, Gabbe BJ. Incidence, costs and predictors of non-union, delayed union and mal-union following long bone fracture. Int J Environ Res Public Health. 2018, 15:10.3390\/ijerph15122845","journal-title":"Int J Environ Res Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge C","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019, 4:5. 10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-3467(07)60142-6","article-title":"Writing narrative literature reviews for peer-reviewed journals: secrets of the trade","volume":"5","author":"Green BN","year":"2006","unstructured":"Green BN, Johnson CD, Adams A. Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med. 2006, 5:101-17. 10.1016\/S0899-3467(07)60142-6","journal-title":"J Chiropr Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1179\/2047480615Z.000000000329","article-title":"Writing narrative style literature reviews","volume":"24","author":"Ferrari R","year":"2015","unstructured":"Ferrari R. Writing narrative style literature reviews. Med Writing. 2015, 24:230-235. 10.1179\/2047480615Z.000000000329","journal-title":"Med Writing"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.O.00055","article-title":"Nonsteroidal anti-inflammatory drugs and bone-healing: a systematic review of research quality","volume":"4","author":"Marquez-Lara A","year":"2016","unstructured":"Marquez-Lara A, Hutchinson ID, Nu\u00f1ez F Jr, et al.. Nonsteroidal anti-inflammatory drugs and bone-healing: a systematic review of research quality. JBJS Rev. 2016, 4:10.2106\/JBJS.RVW.O.00055","journal-title":"JBJS Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.J.01743","article-title":"The effect of nonsteroidal anti-inflammatory drug administration on acute phase fracture-healing: a review","volume":"94","author":"Kurmis AP","year":"2012","unstructured":"Kurmis AP, Kurmis TP, O'Brien JX, Dal\u00e9n T. The effect of nonsteroidal anti-inflammatory drug administration on acute phase fracture-healing: a review. J Bone Joint Surg Am. 2012, 94:815-23. 10.2106\/JBJS.J.01743","journal-title":"J Bone Joint Surg Am"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/OI9.0000000000000092","article-title":"The effect of NSAIDs on postfracture bone healing: a meta-analysis of randomized controlled trials","volume":"4","author":"Al Farii H","year":"2021","unstructured":"Al Farii H, Farahdel L, Frazer A, et al.. The effect of NSAIDs on postfracture bone healing: a meta-analysis of randomized controlled trials. OTA Int. 2021, 4:e092. 10.1097\/OI9.0000000000000092","journal-title":"OTA Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1460408619886211","article-title":"Effects of NSAID use on bone healing: a meta-analysis of retrospective case-control and cohort studies within clinical settings","volume":"22","author":"Ali MU","year":"2019","unstructured":"Ali MU, Usman M, Patel K. Effects of NSAID use on bone healing: a meta-analysis of retrospective case-control and cohort studies within clinical settings. Trauma. 2019, 22:94-111. 10.1177\/1460408619886211","journal-title":"Trauma"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/606404","article-title":"Do nonsteroidal anti-inflammatory drugs affect bone healing? A critical analysis","volume":"2012","author":"Pountos I","year":"2012","unstructured":"Pountos I, Georgouli T, Calori GM, Giannoudis PV. Do nonsteroidal anti-inflammatory drugs affect bone healing? A critical analysis. ScientificWorldJournal. 2012, 2012:606404. 10.1100\/2012\/606404","journal-title":"ScientificWorldJournal"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-010-9379-7","article-title":"NSAID exposure and risk of nonunion: a meta-analysis of case-control and cohort studies","volume":"87","author":"Dodwell ER","year":"2010","unstructured":"Dodwell ER, Latorre JG, Parisini E, et al.. NSAID exposure and risk of nonunion: a meta-analysis of case-control and cohort studies. Calcif Tissue Int. 2010, 87:193-202. 10.1007\/s00223-010-9379-7","journal-title":"Calcif Tissue Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.19.01415","article-title":"Risk of nonunion with nonselective NSAIDs, COX-2 inhibitors, and opioids","volume":"102","author":"George MD","year":"2020","unstructured":"George MD, Baker JF, Leonard CE, et al.. Risk of nonunion with nonselective NSAIDs, COX-2 inhibitors, and opioids. J Bone Joint Surg Am. 2020, 102:1230-8. 10.2106\/JBJS.19.01415","journal-title":"J Bone Joint Surg Am"},{"key":"ref18","article-title":"Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion","volume":"85","author":"Burd TA","year":"2003","unstructured":"Burd TA, Hughes MS, Anglen JO. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. J Bone Joint Surg Br. 2003, 85:700-5.","journal-title":"J Bone Joint Surg Br"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis E","year":"2007","unstructured":"Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007, 18:1319-28. 10.1007\/s00198-007-0394-0","journal-title":"Osteoporos Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1588-2","article-title":"Glucocorticoid-induced osteoporosis: an update","volume":"61","author":"Compston J","year":"2018","unstructured":"Compston J. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018, 61:7-16. 10.1007\/s12020-018-1588-2","journal-title":"Endocrine"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-006-0019-1","article-title":"The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis","volume":"79","author":"van Staa TP","year":"2006","unstructured":"van Staa TP. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int. 2006, 79:129-37. 10.1007\/s00223-006-0019-1","journal-title":"Calcif Tissue Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.2.241","article-title":"Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2","volume":"166","author":"Gage BF","year":"2006","unstructured":"Gage BF, Birman-Deych E, Radford MJ, et al.. Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med. 2006, 166:241-6. 10.1001\/archinte.166.2.241","journal-title":"Arch Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2662-0","article-title":"Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation","volume":"25","author":"Misra D","year":"2014","unstructured":"Misra D, Zhang Y, Peloquin C, et al.. Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation. Osteoporos Int. 2014, 25:1677-84. 10.1007\/s00198-014-2662-0","journal-title":"Osteoporos Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7326\/M19-3671","article-title":"Association between treatment with apixaban, dabigatran, rivaroxaban, or warfarin and risk for osteoporotic fractures among patients with atrial fibrillation: a population-based cohort study","volume":"173","author":"Lau WC","year":"2020","unstructured":"Lau WC, Cheung CL, Man KK, et al.. Association between treatment with apixaban, dabigatran, rivaroxaban, or warfarin and risk for osteoporotic fractures among patients with atrial fibrillation: a population-based cohort study. Ann Intern Med. 2020, 173:1-9. 10.7326\/M19-3671","journal-title":"Ann Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2006.07.022","article-title":"Fracture risk in users of oral anticoagulants: a nationwide case-control study","volume":"118","author":"Rejnmark L","year":"2007","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol. 2007, 118:338-44. 10.1016\/j.ijcard.2006.07.022","journal-title":"Int J Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.896952","article-title":"Comparative risks of fracture among direct oral anticoagulants and warfarin: a systematic review and network meta-analysis","volume":"9","author":"Tsai SH","year":"2022","unstructured":"Tsai SH, Hu CW, Shao SC, et al.. Comparative risks of fracture among direct oral anticoagulants and warfarin: a systematic review and network meta-analysis. Front Cardiovasc Med. 2022, 9:896952. 10.3389\/fcvm.2022.896952","journal-title":"Front Cardiovasc Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.7.1169","article-title":"The effect of anticoagulant pharmacotherapy on fracture healing","volume":"9","author":"Lindner T","year":"2008","unstructured":"Lindner T, Cockbain AJ, El Masry MA, et al.. The effect of anticoagulant pharmacotherapy on fracture healing. Expert Opin Pharmacother. 2008, 9:1169-87. 10.1517\/14656566.9.7.1169","journal-title":"Expert Opin Pharmacother"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019618","article-title":"Fracture risks in patients treated with different oral anticoagulants: a systematic review and meta-analysis","volume":"10","author":"Huang HK","year":"2021","unstructured":"Huang HK, Peng CC, Lin SM, et al.. Fracture risks in patients treated with different oral anticoagulants: a systematic review and meta-analysis. J Am Heart Assoc. 2021, 10:e019618. 10.1161\/JAHA.120.019618","journal-title":"J Am Heart Assoc"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1778-8","article-title":"Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies","volume":"23","author":"Wu Q","year":"2012","unstructured":"Wu Q, Bencaz AF, Hentz JG, Crowell MD. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. Osteoporos Int. 2012, 23:365-75. 10.1007\/s00198-011-1778-8","journal-title":"Osteoporos Int"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1554","article-title":"Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis","volume":"27","author":"Eom CS","year":"2012","unstructured":"Eom CS, Lee HK, Ye S, et al.. Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis. J Bone Miner Res. 2012, 27:1186-95. 10.1002\/jbmr.1554","journal-title":"J Bone Miner Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2015-9","article-title":"Relationship between use of antidepressants and risk of fractures: a meta-analysis","volume":"24","author":"Rabenda V","year":"2013","unstructured":"Rabenda V, Nicolet D, Beaudart C, et al.. Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos Int. 2013, 24:121-37. 10.1007\/s00198-012-2015-9","journal-title":"Osteoporos Int"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31817d5943","article-title":"Fracture risk from psychotropic medications: a population-based analysis","volume":"28","author":"Bolton JM","year":"2008","unstructured":"Bolton JM, Metge C, Lix L, et al.. Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol. 2008, 28:384-91. 10.1097\/JCP.0b013e31817d5943","journal-title":"J Clin Psychopharmacol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.2.188","article-title":"Effect of selective serotonin reuptake inhibitors on the risk of fracture","volume":"167","author":"Richards JB","year":"2007","unstructured":"Richards JB, Papaioannou A, Adachi JD, et al.. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007, 167:188-94. 10.1001\/archinte.167.2.188","journal-title":"Arch Intern Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang YX","year":"2006","unstructured":"Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006, 296:2947-53. 10.1001\/jama.296.24.2947","journal-title":"JAMA"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.01.007","article-title":"Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies","volume":"124","author":"Yu EW","year":"2011","unstructured":"Yu EW, Bauer SR, Bain PA, Bauer DC. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med. 2011, 124:519-26. 10.1016\/j.amjmed.2011.01.007","journal-title":"Am J Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.11.014","article-title":"Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss","volume":"138","author":"Targownik LE","year":"2010","unstructured":"Targownik LE, Lix LM, Leung S, Leslie WD. Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology. 2010, 138:896-904. 10.1053\/j.gastro.2009.11.014","journal-title":"Gastroenterology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.113","article-title":"Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies","volume":"106","author":"Ngamruengphong S","year":"2011","unstructured":"Ngamruengphong S, Leontiadis GI, Radhi S, et al.. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies. Am J Gastroenterol. 2011, 106:1209-18; quiz 1219. 10.1038\/ajg.2011.113","journal-title":"Am J Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2017.11.006","article-title":"Diabetes and healing outcomes in lower extremity fractures: a systematic review","volume":"49","author":"Gortler H","year":"2018","unstructured":"Gortler H, Rusyn J, Godbout C, et al.. Diabetes and healing outcomes in lower extremity fractures: a systematic review. Injury. 2018, 49:177-83. 10.1016\/j.injury.2017.11.006","journal-title":"Injury"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.080486","article-title":"Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis","volume":"180","author":"Loke YK","year":"2009","unstructured":"Loke YK, Singh S, Furberg CD. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ. 2009, 180:32-9. 10.1503\/cmaj.080486","journal-title":"CMAJ"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-015-0286-8","article-title":"Diabetes and its effect on bone and fracture healing","volume":"13","author":"Jiao H","year":"2015","unstructured":"Jiao H, Xiao E, Graves DT. Diabetes and its effect on bone and fracture healing. Curr Osteoporos Rep. 2015, 13:327-35. 10.1007\/s11914-015-0286-8","journal-title":"Curr Osteoporos Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher RL","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014, 13:57-65. 10.1517\/14740338.2013.827660","journal-title":"Expert Opin Drug Saf"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1041-2972.2005.0020.x","article-title":"Polypharmacy in the elderly: a literature review","volume":"17","author":"Fulton MM","year":"2005","unstructured":"Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005, 17:123-32. 10.1111\/j.1041-2972.2005.0020.x","journal-title":"J Am Acad Nurse Pract"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61091-5","article-title":"Appropriate prescribing in elderly people: how well can it be measured and optimized?","volume":"370","author":"Spinewine A","year":"2007","unstructured":"Spinewine A, Schmader KE, Barber N, et al.. Appropriate prescribing in elderly people: how well can it be measured and optimized?. Lancet. 2007, 370:173-184. 10.1016\/S0140-6736(07)61091-5","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-018-0554-2","article-title":"International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): position statement and 10 recommendations for action","volume":"35","author":"Mangin D","year":"2018","unstructured":"Mangin D, Bahat G, Golomb BA, et al.. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): position statement and 10 recommendations for action. Drugs Aging. 2018, 35:575-87. 10.1007\/s40266-018-0554-2","journal-title":"Drugs Aging"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott IA","year":"2015","unstructured":"Scott IA, Hilmer SN, Reeve E, et al.. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015, 175:827-34. 10.1001\/jamainternmed.2015.0324","journal-title":"JAMA Intern Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-3007-8","article-title":"Bisphosphonates and their influence on fracture healing: a systematic review","volume":"26","author":"Molvik H","year":"2015","unstructured":"Molvik H, Khan W. Bisphosphonates and their influence on fracture healing: a systematic review. Osteoporos Int. 2015, 26:1251-60. 10.1007\/s00198-014-3007-8","journal-title":"Osteoporos Int"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins","volume":"286","author":"Mundy G","year":"1999","unstructured":"Mundy G, Garrett R, Harris S, et al.. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999, 286:1946-9. 10.1126\/science.286.5446.1946","journal-title":"Science"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2008.12.011","article-title":"Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy","volume":"34","author":"Rozental TD","year":"2009","unstructured":"Rozental TD, Vazquez MA, Chacko AT, et al.. Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy. J Hand Surg Am. 2009, 34:595-602. 10.1016\/j.jhsa.2008.12.011","journal-title":"J Hand Surg Am"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.89B12.19671","article-title":"Inhibition of fracture healing","volume":"89","author":"Gaston MS","year":"2007","unstructured":"Gaston MS, Simpson AH. Inhibition of fracture healing. J Bone Joint Surg Br. 2007, 89:1553-60. 10.1302\/0301-620X.89B12.19671","journal-title":"J Bone Joint Surg Br"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003042","article-title":"Effects of statins on bone mineral density and fracture risk: a PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Wang Z","year":"2016","unstructured":"Wang Z, Li Y, Zhou F, Piao Z, Hao J. Effects of statins on bone mineral density and fracture risk: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016, 95:e3042. 10.1097\/MD.0000000000003042","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/455881-fracture-healing-and-commonly-co-prescribed-medications-orthopedic-implications-in-multimorbid-patients-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:01:37Z","timestamp":1775120497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/455881-fracture-healing-and-commonly-co-prescribed-medications-orthopedic-implications-in-multimorbid-patients-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.106315","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,2]]}}}